Navigation Links
New generation of orthopedic, dental and cardiovascular prostheses
Date:1/27/2009

faces with a sponge-like pattern of nano (ultra small) pits. "We demonstrated that some cells stick better to these surfaces than they do to the traditional smooth ones," says Dr. Nanci. "This is already an improvement to the standard available biomaterial."

The researchers then tested the effects of the chemically-produced nanoporous titanium surfaces on cell growth and development. They showed that the treated surfaces increased growth of bone cells, decreased growth of unwanted cells and stimulated stem cells, relative to untreated smooth ones. In addition, expression of genes required for cell adhesion and growth were increased in contact with the nanoporous surfaces.

Different etchants have different effects

Uncontrolled growth of cells on an implant is not ideal. For example, when using cardiovascular stents, it is important to limit the growth of certain cells in order not interfere with blood flow. Also, in some cases, cells can form an undesirable capsule around dental implants causing them to fall. The scientists demonstrated that treatment with specific etchants reduced the growth of unwanted cells.

"An important element of this study is how we demonstrated the selective cellular effects of etching," says Dr. Nanci. "With subtle changes in chemical composition of etching mixtures, we can alter the nanopatterns that are created on the metal surface and control consequent cellular responses."

"Our study is groundbreaking," adds Dr. Nanci. "We use simple yet very efficient chemical treatments to alter metals commonly used in the operating room. This innovative approach may ultimately hold the key to developing intelligent materials that are not only easily accepted by the human body but that can actively respond to the surrounding biological environment."


'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

Page: 1 2

Related biology news :

1. Next generation microscopy: No stain, big gain
2. e-Smart Technologies to Introduce Next Generation I AM Smart Card Technology at Cartes 2008 in Paris
3. Gene therapy restores vision to mice with retinal degeneration
4. Cholesterol-lowering drugs and the effect on muscle repair and regeneration
5. Generation innovation: Young UC San Diego bioengineer to use NIH grant to fuel tissue engineering
6. ESA trains next generation of atmospheric scientists
7. Entrust Expands Relationship with Slovenia, Implements Second-generation ePassport Solution
8. Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
9. Songbirds may hold key to advances in treatment of brain degeneration
10. Broad Institute researchers introduce next generation tool for visualizing genomic data
11. The epigenetics of increasing weight through the generations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ns like frogs and toads have existed for 360 milli...ut a new aquatic fungus is threatening to make man...November issue of Microbiology Today . , The f...found to be associated with waves of amphibian ext...ralia in the 1990,s. Bd infects over 350 amphibian...
(Date:11/23/2009)...study from Perth,s Telethon Institute for Child He...nd timing of alcohol consumption in pregnancy affe...dy has just been published online in the internati...O,Leary said the analysis was drawn from a random ...uestionnaire three months after the baby,s deliver...
(Date:11/23/2009)...erflows are a nasty business, posing dangers to hu...te University is launching a new project with fund...(EPA) that targets the fat and grease that contrib...give urban planners new tools to further reduce th...s from "sanitary" sewer systems, as opposed to "co...
Breaking Biology News(10 mins):New study links alcohol in pregnancy to child behavior problems 2Lose the fat: Targeting grease to curtail sewer overflows 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 43SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 53SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 63SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 73SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 83SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 93SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 103SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 113SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 123SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 133SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 143SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 153SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 163SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 173SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 183SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 193SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 203SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 213SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 223SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 233SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 243SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 25HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference 54260 1Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 1Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 2
... a GSK company focused on discovering and developi... such as Type 2 Diabetes, announced today that it ... of sirtuin research and its potential to treat di...rial disorders, inflammation, cancer, and heart di...ets to Treat Age-Associated Diseases," the review ...
...in the October 2008 issue of BioScience are as fol...st with a Molecular Master. , Kabir G. Peay, Pet...chniques have in recent years allowed the systemat...ime. Results show extremely high diversity and var...lanation for which is unknown. High-throughput DNA...
...ronmental benefit for shade-grown Latin American c...technique will provide a buffer against the ravage... the last three decades, many Latin American coffe... techniques, in which the plants are grown beneath...se production, much of the acreage has been conver...
Other Biology News:Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery 2BioScience tip sheet, October 2008 2BioScience tip sheet, October 2008 3Green coffee-growing practices buffer climate-change impacts 2
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Sigma-AldrichCorporati...ferenceonTuesday,December1stat1:45PMGMTinLondon,7:...roadcastovertheInternetavailableat http://inve s..."Webcast"icontoaccessthisfile. ,, AboutSigma-...hTechnologycompany.Itschemicalandbiochemicalproduc...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe...pprovedthe,investigationalnewdrugapplication(IND)f...informulationtotreatdiabetes.ThisIND,approvalallow..., Diabetesisadisordercharacteristicofhighbloodgl...oftenresultinseveremicro-and,macro-vasculardisease...
(Date:11/24/2009)...mber24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NA...ompany,today,announcedthatithassubmittedaMAAtotheE...pany,senzymereplacementtherapyindevelopment,forthe...ting,applicationforvelaglucerasealfathathasbeensub...dCanada. , Basedonaglobalsupplyshortageofthec...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...this is my last article of the year, and I have ta..., so my New Year,s resolution for this column is b...ck, or folk-related). Part of the problem is that ...st year, or bought many new CDs (something else I ...us has been more on biotech,s international side a...
...irst spot on Google , Yahoo , or MSN , all it u...xperts aren,t sure exactly what it,s going to take... pay-per click (PPC) infrastructures to increase t...duce the ranking for ads promoting link farms and .... , ,The benefits of these updates to search engin...
...s. - The nation,s space agency announced this mon... long enough to pack for the longer trip to Mars ...dministration should bypass the Earth,s lifeles...where there are tantalizing signs of water. Still ...siness of space flight and let private entrepreneu...
Other Biology Technology:2006: A great biotech financing year, unless you were going public! 22006: A great biotech financing year, unless you were going public! 32006: A great biotech financing year, unless you were going public! 42006: A great biotech financing year, unless you were going public! 5It takes more than money to reach the top 2It takes more than money to reach the top 3It takes more than money to reach the top 4Flying to the moon? Take Wisconsin tech along 2Flying to the moon? Take Wisconsin tech along 3Flying to the moon? Take Wisconsin tech along 4
Rabbit Anti-Human BAR Antibody, Unconjugated from CHEMICON
Anti-UbcH7 Antibody, Unconjugated from CHEMICON
Mouse Anti-Mouse TCR, DO11.10 Monoclonal Antibody, Biotin Conjugated, Clone KJ1-26 from CEDARLANE Laboratories Limited
Mouse Anti-5-Methylcytosine Monoclonal Antibody, Unconjugated, Clone 33D3 from Eurogentec
Biology Products: